Literature DB >> 15860891

Genetic cancer risk assessment in the newly diagnosed breast cancer patient is useful and possible in practice.

Melanie R Palomares, Benjamin Paz, Jeffrey N Weitzel.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15860891     DOI: 10.1200/JCO.2005.05.157

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs.

Authors:  Carin R Espenschied; Deborah J MacDonald; Julie O Culver; Sharon Sand; Karen Hurley; Kimberly C Banks; Jeffrey N Weitzel; Kathleen R Blazer
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

2.  Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.

Authors:  E Zilliacus; B Meiser; M Gleeson; K Watts; K Tucker; E A Lobb; G Mitchell
Journal:  Support Care Cancer       Date:  2012-03-24       Impact factor: 3.603

3.  If we build it ... will they come?--establishing a cancer genetics services clinic for an underserved predominantly Latina cohort.

Authors:  Charité Ricker; Veronica Lagos; Nancy Feldman; Susan Hiyama; Sue Fuentes; Visanth Kumar; Kelly Gonzalez; Melanie Palomares; Kathleen Blazer; Katrina Lowstuter; Deborah MacDonald; Jeffrey Weitzel
Journal:  J Genet Couns       Date:  2006-12       Impact factor: 2.537

4.  Family history of pancreatic cancer in a high-risk cancer clinic: implications for risk assessment.

Authors:  Michael J Hall; James J Dignam; Olufunmilayo I Olopade
Journal:  J Genet Couns       Date:  2008-06-25       Impact factor: 2.537

5.  Barriers to the use of personalized medicine in breast cancer.

Authors:  Christine B Weldon; Julia R Trosman; William J Gradishar; Al B Benson; Julian C Schink
Journal:  J Oncol Pract       Date:  2012-05-22       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.